{'fraction_non_alphanumeric': 0.033236994219653176, 'fraction_numerical': 0.008670520231213872, 'mean_word_length': 5.663461538461538, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
IMPACT OF DOSING REGIMEN ON CONSUMPTION OF CALCIUM SUPPLEMENTS FOR PREVENTION OF PREECLAMPSIA AMONG ANTENATAL CARE CLIENTS: A CLUSTER‐RANDOMIZED, NON‐INFERIORITY TRIAL IN WESTERN KENYA

To prevent pre‐eclampsia, the World Health Organization (WHO) recommends ante‐natal calcium (Ca) supplementation in populations with inadequate habitual intake. The WHO guideline recommends 1.5–2.0 g /d with a dosing regimen that might require 4–5 pill‐taking events when iron and folic acid (IFA) supplements are also taken. We hypothesized that simpler regimens with lower daily dosages might lead to higher adherence, and therefore have the same impact on supplemental calcium intake while costing less.